Series B · Robotics
Multiply Labs: Series B
Multiply Labs builds robotics for manufacturing personalized medicines, helping drug makers produce individualized treatments with less manual work.
The business
Multiply Labs applies robotics to the production of individualized medicines, a process that has traditionally depended on slow, labor-intensive manufacturing. Its systems are designed to automate repeatable steps while accommodating therapies made for specific patients. By bringing robotics into advanced-therapy manufacturing, the company aims to help manufacturers increase capacity and make personalized treatments more practical to produce.
Funding history
Series B · This round$75M